Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-03-15 @ 7:56 AM
Study NCT ID:
NCT00276003
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-01-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Sponsor:
Organization: